Detalhe da pesquisa
1.
Soluble Fas affects erythropoiesis in vitro and acts as a potential predictor of erythropoiesis-stimulating agent therapy in patients with chronic kidney disease.
Am J Physiol Renal Physiol
; 318(4): F861-F869, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32003597